ES2078019T3 - Amidas de alcanoil l-carnitina con aminoacidos y composiciones farmaceuticas que las contienen para promover regeneracion del tejido nervioso, inhibir degeneracion neuronal, mejorar el proceso de aprendimiento y memoria y para el tratamiento de coma. - Google Patents
Amidas de alcanoil l-carnitina con aminoacidos y composiciones farmaceuticas que las contienen para promover regeneracion del tejido nervioso, inhibir degeneracion neuronal, mejorar el proceso de aprendimiento y memoria y para el tratamiento de coma.Info
- Publication number
- ES2078019T3 ES2078019T3 ES92830224T ES92830224T ES2078019T3 ES 2078019 T3 ES2078019 T3 ES 2078019T3 ES 92830224 T ES92830224 T ES 92830224T ES 92830224 T ES92830224 T ES 92830224T ES 2078019 T3 ES2078019 T3 ES 2078019T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- learning
- carnitine
- amides
- nervous tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000008929 regeneration Effects 0.000 title abstract 2
- 238000011069 regeneration method Methods 0.000 title abstract 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title 1
- 206010010071 Coma Diseases 0.000 title 1
- 150000001408 amides Chemical class 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 L-CARNITINE AMIDES Chemical class 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000002699 waste material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
AMIDAS DE L-CARNITINAS DE ALKANOIL DE LA FORMULA GENERAL (1). EN DONDE R ES UN GRUPO ALKANOIL PURO O RAMIFICADO QUE TIENE DE 2 A 8 ATOMOS DE CARBONO SELECCIONADOS DE ACETIL, PROPIONIL, BUTIRIL, ISOBUTIRIL, VALERIL, ISOVALERIL, HEXANOIL, 1METILBUTIRIL, T-BUTILACETIL, 2-ETILBUTIRIL, 3-METILVALERIL, 4METILVALERIL, 2-ETILHEXANOIL Y 2-PROPILPENTANOIL; R'' ES EL RESIDUO MONOVALENTE DE UN AMINOACIDO PRODUCIDO DE FORMA NATURAL SELECCIONADO DE: Y X TABLE ACTIVO EN LA REGENERACION DEL TEJIDO NERVIOSO, INHIBICION DE LA DEGENERACION NEURONAL, MEJORIA DE LOS PROCESOS DE APRENDIZAJE Y MEMORIA Y PARA EL TRATAMIENTO DEL COMA. COMPOSICIONES DE ADMINISTRACION ORAL O PARENTERAL EN FORMA DE DOSIS UNITARIA COMPRENDEN ENTRE 50 Y 500 MG DE UNA AMIDA DE LA FORMULA (1).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM910333A IT1248323B (it) | 1991-05-16 | 1991-05-16 | Ammidi con amminoacidi naturali di alcanoil l-carnitine quali inibitori della degenerazione neuronale e attivatori dei processi di apprendimento e memorizzazione e per il trattamento del coma e composizioni farmaceutiche comprendenti tali composti |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2078019T3 true ES2078019T3 (es) | 1995-12-01 |
Family
ID=11400146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92830224T Expired - Lifetime ES2078019T3 (es) | 1991-05-16 | 1992-05-14 | Amidas de alcanoil l-carnitina con aminoacidos y composiciones farmaceuticas que las contienen para promover regeneracion del tejido nervioso, inhibir degeneracion neuronal, mejorar el proceso de aprendimiento y memoria y para el tratamiento de coma. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5270472A (es) |
EP (1) | EP0514359B1 (es) |
JP (1) | JP3222195B2 (es) |
AT (1) | ATE127780T1 (es) |
CA (1) | CA2068752C (es) |
DE (1) | DE69204737T2 (es) |
DK (1) | DK0514359T3 (es) |
ES (1) | ES2078019T3 (es) |
GR (1) | GR3017456T3 (es) |
HK (1) | HK1005863A1 (es) |
IE (1) | IE921575A1 (es) |
IT (1) | IT1248323B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1254314B (it) * | 1992-03-27 | 1995-09-14 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari. |
US5607691A (en) * | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
IT1276225B1 (it) * | 1995-10-17 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per |
IT1276253B1 (it) | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
US5863940A (en) | 1997-12-01 | 1999-01-26 | Sigma-Tau Healthscience S.P.A. | Medicament and therapeutical method for treating idiopathic asthenozoospermia |
US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
US5958886A (en) * | 1998-01-13 | 1999-09-28 | Sigma-Tau Pharmaceuticals, Inc. | Carnitine-containing peptides and a method for using the same |
ES2210705T5 (es) | 1998-03-19 | 2011-02-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Composición combinada que comprende una l-carnitina o una alcanoil-l-carnitina, un glucosaminoglucano y/o un constituyente del mismo. |
IT1306186B1 (it) * | 1999-09-03 | 2001-05-30 | Biosalts Srl | Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale |
IT1316998B1 (it) * | 2000-03-02 | 2003-05-26 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori. |
CN1995010B (zh) * | 2006-12-29 | 2012-12-12 | 辽宁科硕营养科技有限公司 | 一种合成丙酰左旋肉碱盐酸盐的方法 |
EP2582368B1 (en) | 2010-06-16 | 2018-05-09 | Alfasigma S.p.A. | Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue |
US9572848B1 (en) | 2014-03-26 | 2017-02-21 | Aemes Research L.L.L.P. | Composition of matter for sexual dysfunction |
CN112851747B (zh) * | 2019-11-12 | 2024-03-05 | 深圳翰宇药业股份有限公司 | 一种含季铵碱衍生物修饰的多肽合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1116037B (it) * | 1979-04-23 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico |
IT1144077B (it) * | 1980-01-29 | 1986-10-29 | Sigma Tau Ind Farmaceuti | Carnitinammidi di amminoacidi otticamente attivi e procedimento per la loro preparazione |
-
1991
- 1991-05-16 IT ITRM910333A patent/IT1248323B/it active IP Right Grant
-
1992
- 1992-05-14 EP EP92830224A patent/EP0514359B1/en not_active Expired - Lifetime
- 1992-05-14 DK DK92830224.9T patent/DK0514359T3/da active
- 1992-05-14 DE DE69204737T patent/DE69204737T2/de not_active Expired - Fee Related
- 1992-05-14 ES ES92830224T patent/ES2078019T3/es not_active Expired - Lifetime
- 1992-05-14 AT AT92830224T patent/ATE127780T1/de not_active IP Right Cessation
- 1992-05-15 CA CA002068752A patent/CA2068752C/en not_active Expired - Fee Related
- 1992-05-15 JP JP12372592A patent/JP3222195B2/ja not_active Expired - Fee Related
- 1992-05-15 US US07/883,388 patent/US5270472A/en not_active Expired - Lifetime
- 1992-07-01 IE IE157592A patent/IE921575A1/en not_active IP Right Cessation
-
1995
- 1995-09-21 GR GR950402156T patent/GR3017456T3/el unknown
-
1998
- 1998-06-05 HK HK98104938A patent/HK1005863A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR3017456T3 (en) | 1995-12-31 |
US5270472A (en) | 1993-12-14 |
DK0514359T3 (da) | 1995-11-13 |
ITRM910333A0 (it) | 1991-05-16 |
IE921575A1 (en) | 1992-11-18 |
IT1248323B (it) | 1995-01-05 |
HK1005863A1 (en) | 1999-01-29 |
DE69204737T2 (de) | 1996-02-29 |
EP0514359A3 (en) | 1993-03-10 |
EP0514359A2 (en) | 1992-11-19 |
CA2068752C (en) | 2003-01-14 |
JP3222195B2 (ja) | 2001-10-22 |
DE69204737D1 (de) | 1995-10-19 |
ATE127780T1 (de) | 1995-09-15 |
EP0514359B1 (en) | 1995-09-13 |
ITRM910333A1 (it) | 1992-11-16 |
JPH0649004A (ja) | 1994-02-22 |
CA2068752A1 (en) | 1992-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2078019T3 (es) | Amidas de alcanoil l-carnitina con aminoacidos y composiciones farmaceuticas que las contienen para promover regeneracion del tejido nervioso, inhibir degeneracion neuronal, mejorar el proceso de aprendimiento y memoria y para el tratamiento de coma. | |
UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
KR920702216A (ko) | 아세틸 d-카르니틴의 녹내장 치료에의 용도 | |
KR940008681A (ko) | 디클로페낙 염용 비경구 용액 | |
GEP20032925B (en) | Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake | |
KR920000324A (ko) | 필수 지방산 처리법 | |
FR2388556A1 (fr) | Application therapeutique de l'acetyl-carnitine-d,1 et d'autres derives acyliques de la carnitine-d,1 | |
KR940018089A (ko) | 내부조직의 방사선 손상에 대한 예방 및 처치방법 | |
DE68911891D1 (de) | Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung. | |
KR910007858A (ko) | 초기-촉진 및 향상된 진통제로서의 s(+)-이부프로펜-l-아미노산 및 s(+)-이부프로펜-d-아미노산 | |
ES2057837T3 (es) | Esteres de acil l-carnitinas con acido gamma-hidroxibutirico y composiciones farmaceuticas que los contienen para inhibir degeneracion neuronal y para el tratamiento de coma. | |
ATE177950T1 (de) | Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis | |
KR970025615A (ko) | 암 전이 억제제 | |
IT1224842B (it) | Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso | |
ES2070478T3 (es) | El empleo de acetil l-carnitina en el tratamiento terapeutico de coma. | |
RO117760B1 (ro) | Metodă pentru tratamentul unei afecţiuni de neurotransmisie serotoninergică defectivă | |
ES2056620T3 (es) | Esteres de (r) (-)-carnitina y acil (r) (-)-carnitinas con acido beta hidroxibutirico y composiciones farmaceuticas que las contienen para inhibir la degeneracion neuronal, proteolisis de higado y para el tratamiento de coma. | |
HU9303000D0 (en) | Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof | |
ES427079A1 (es) | Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7. | |
ES2067206T3 (es) | Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria. | |
JPS57126420A (en) | Drug for digestive organ | |
IT1256178B (it) | Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
US3786143A (en) | Method for treating virus infection affecting the brain | |
KR950702528A (ko) | 엔^지(n^g)-모노메틸-엘(l)-아르기닌 염화수소 유도체 및 패혈증성 쇼크의 치료에 있어서의 이들의 용도, (n^g-monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock) | |
EP0228314A3 (en) | Use of ethanol/amine derivatives in treating or preventing hyperlipemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 514359 Country of ref document: ES |